Department of Anatomy, Physiology, and Genetics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Neuroscience. 2012 Sep 27;221:157-69. doi: 10.1016/j.neuroscience.2012.07.006. Epub 2012 Jul 13.
Kainate receptors containing the GluK1 subunit (GluK1Rs; previously known as GluR5 kainate receptors) are concentrated in certain brain regions, where they play a prominent role in the regulation of neuronal excitability, by modulating GABAergic and/or glutamatergic synaptic transmission. In the basolateral nucleus of the amygdala (BLA), which plays a central role in anxiety as well as in seizure generation, GluK1Rs modulate GABAergic inhibition via postsynaptic and presynaptic mechanisms. However, the role of these receptors in the regulation of glutamate release, and the net effect of their activation on the excitability of the BLA network are not well understood. Here, we show that in amygdala slices from 35- to 50-day-old rats, the GluK1 agonist (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA) (300 nM) increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) and miniature EPSCs (mEPSCs) recorded from BLA principal neurons, and decreased the rate of failures of evoked EPSCs. The GluK1 antagonist (S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxybenzyl) pyrimidine-2,4-dione (UBP302) (25 or 30 μM) decreased the frequency of mEPSCs, reduced evoked field potentials, and increased the "paired-pulse ratio" of the field potential amplitudes. Taken together, these results suggest that GluK1Rs in the rat BLA are present on presynaptic terminals of principal neurons, where they mediate facilitation of glutamate release. In vivo bilateral microinjections of ATPA (250 pmol) into the rat BLA increased anxiety-like behavior in the open field test, while 2 nmol ATPA induced seizures. Similar intra-BLA injections of UBP302 (20 nmol) had anxiolytic effects in the open field and the acoustic startle response tests, without affecting pre-pulse inhibition. These results suggest that although GluK1Rs in the rat BLA facilitate both GABA and glutamate release, the facilitation of glutamate release prevails, and these receptors can have an anxiogenic and seizurogenic net function. Presynaptic facilitation of glutamate release may, in part, underlie the hyperexcitability-promoting effects of GluK1R activation in the rat BLA.
包含 GluK1 亚基的红藻氨酸受体(GluK1Rs;以前称为 GluR5 红藻氨酸受体)集中在某些脑区,在那里通过调节 GABA 能和/或谷氨酸能突触传递,它们在神经元兴奋性的调节中起重要作用。在杏仁核基底外侧核(BLA)中,GluK1Rs 通过突触后和突触前机制调节 GABA 能抑制,BLA 在焦虑以及癫痫发作的产生中起核心作用。然而,这些受体在调节谷氨酸释放中的作用,以及它们的激活对 BLA 网络兴奋性的净效应尚不清楚。在这里,我们表明,在来自 35-50 天大鼠的杏仁核切片中,红藻氨酸受体激动剂(RS)-2-氨基-3-(3-羟基-5-叔丁基异恶唑-4-基)丙氨酸(ATPA)(300 nM)增加了从 BLA 主神经元记录的自发兴奋性突触后电流(sEPSC)和微小 EPSC(mEPSC)的频率,并降低了诱发 EPSC 失败的速率。红藻氨酸受体拮抗剂(S)-1-(2-氨基-2-羧乙基)-3-(2-羧基苄基)嘧啶-2,4-二酮(UBP302)(25 或 30 μM)降低了 mEPSC 的频率,减少了诱发的场电位,并增加了场电位幅度的“成对脉冲比”。总之,这些结果表明,大鼠 BLA 中的 GluK1Rs 存在于主神经元的突触前末端,在那里它们介导谷氨酸释放的易化。在大鼠 BLA 双侧立体定位微注射 ATPA(250 pmol)增加了旷场测试中的焦虑样行为,而 2 nmol ATPA 诱导了癫痫发作。类似的 BLA 内注射 UBP302(20 nmol)在旷场和听觉惊跳反应测试中具有抗焦虑作用,而不影响预脉冲抑制。这些结果表明,尽管大鼠 BLA 中的 GluK1Rs 促进 GABA 和谷氨酸的释放,但谷氨酸释放的易化占主导地位,这些受体可能具有焦虑和致痫的净功能。谷氨酸释放的突触前易化可能部分解释了 GluK1R 在大鼠 BLA 中激活对过度兴奋的促进作用。